When was PL BioScience founded?

PL BioScience was founded in 2015 and raised its 1st funding round 6 years after it was founded.

Where is PL BioScience located?

PL BioScience is headquartered in Aachen, Germany.

Which legal entities is PL BioScience associated with?

PL BioScience is associated with Pl Bioscience Gmbh and 1 other.

How many employees does PL BioScience have?

As of Aug 31, 2026, the latest employee count at PL BioScience is 33.

Is PL BioScience a funded company?

PL BioScience is a funded company, having raised a total of $13M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on May 25, 2021.

When was the latest funding round of PL BioScience?

PL BioScience's latest funding was a $***** Series A round on Aug 11, 2024, with participation from 6 investors. Its primary sector is Life Sciences Platforms and Tools. In Germany, the Life Sciences Platforms and Tools sector has seen $59.1M in funding in 2026 to date.

Where does PL BioScience rank among its competitors?

PL BioScience ranks 8th amongst 924 active competitors, of which 47 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of PL BioScience?

PL BioScience's top competitors include Abcam, Meridian Bioscience and Enzo. Among them, BioLamina secured the most recent funding round in April, 2026.

PL BioScience - 2026 Company Profile, Team, Funding, Competitors & Financials

PL BioScience is a series A company based in Aachen (Germany), founded in 2015. It operates as a Manufacturer of human platelet lysate products for cell culture applications. PL BioScience has raised $13M in funding from investors like Brightlands Venture Partners, TechVision Fonds and Better Ventures. The company has 924 active competitors, including 47 funded and 96 that have exited. Its top competitors include companies like Abcam, Meridian Bioscience and Enzo.

Company Details

Manufacturer of human platelet lysate products for cell culture applications. The company offers a range of platelet lysate products with different safety grades. These products support cell expansion for research, therapeutics, and clinical applications. The company's technology aims to provide solutions for cell culture needs.

Website: pl-bioscience.com
Email ID: *****@pl-bioscience.com

Key Metrics

Founded Year

2015

Location

Aachen, Germany

Stage

Series A

Total Funding

$13M in 2 rounds

Latest Funding Round

Series A, Aug 11, 2024, $*****

Investors

Brightlands Venture Partners & 19 more

Ranked

8^th among 924 active competitors

Employee Count

33 as on Aug 31, 2026

Similar Companies

Abcam & 1063 more

View PL BioScience's full profile

PL BioScience is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
PL BioScience GmbH CIN: R3101_HRB19554 , Germany, Active	Mar 02, 2015	-	-
Pl Bioscience Gmbh CIN: HRB19554 , Germany, Active	Mar 01, 2015	-	13 (As on Dec 31, 2021)

PL BioScience has raised a total funding of $13M over 2 rounds. Its first funding round was on May 25, 2021. Its latest funding round was a Series A round on Aug 11, 2024 for $*****. 6 investors participated in its latest round. PL BioScience has 11 institutional investors and 9 angel investors.

Here is the list of recent funding rounds of PL BioScience:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 11, 2024	7564906	Series A	6926389	7891610	6939199	2221399
May 25, 2021	3762092	Series A	3945779	4515882	Brightlands Venture Partners & 3 more	8366221

Access funding benchmarks and valuations. Sign up today!

View details of PL BioScience's funding rounds and investors

PL BioScience's employee count trend

PL BioScience has 33 employees as of Aug 26. Here is PL BioScience's employee count trend over the years:

Uncover PL BioScience's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PL BioScience include Abcam, Meridian Bioscience and Enzo. Here is the list of Top 10 competitors of PL BioScience, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
3rd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	65/100
4th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
5th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
6th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
7th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Cambrian Growth Partners, Telegraph Hill Partners ... & 1 others	56/100
8th	PL BioScience 2015, Aachen (Germany), Series A	Manufacturer of human platelet lysate products for cell culture applications	$13M	Better Ventures, S-UBG & 18 others	55/100
9th	Luminex 1995, Austin (United States), Acquired	Developer of instruments, reagents and kits for clinical diagnostics and life science research	-	Public Health Emergency, National Science Foundation ... & 1 others	55/100
10th	Firefly BioWorks 2009, Cambridge (United States), Acquired	Develops platform to allow multiplexed assays on standard laboratory instrumentation	$3.77M	PBM Capital, Breton Capital Ventures & 3 others	54/100